Later in-vitro studies using T cells from COVID-19 patients showed that helminth derived products significantly reduced the frequency of SARS-CoV-2-reactive CD4+T cells, whereas the frequency of SARS-CoV-2-reactive CD8+T cells was unaffected or even increased.62 The gene discussed is CD8A; the disease is COVID-19.